Oncogenic protein tyrosine kinases
Dysfunction of the RET receptor in human cancer
Multi-author Review
- 169 Downloads
- 49 Citations
Abstract.
RET is the receptor for glial-derived neurotrophic factor growth factors. It is a paradigm of a single gene that causes different types of human cancer when targeted by different genetic alterations. Like other receptor tyrosine kinases, once activated, RET recruits a variety of signaling molecules that mediate biological responses. Here we review data on the signaling pathways that lead to RET-mediated cell transformation and recent evidence that manipulation of RET holds promise for thyroid cancer treatment.
Key words.
Thyroid tyrosine kinase inhibitors RET MEN2 papillary thyroid carcinomaPreview
Unable to display preview. Download preview PDF.
Copyright information
© Birkhäuser Verlag, Basel 2004